- Home
- CNTX vs CPIX Comparison
CNTX vs CPIX Comparison
Compare CNTX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- CPIX
- Stock Information
- Founded
- CNTX 2015
- CPIX 1999
- Country
- CNTX United States
- CPIX United States
- Employees
- CNTX N/A
- CPIX N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- CNTX Health Care
- CPIX Health Care
- Exchange
- CNTX Nasdaq
- CPIX Nasdaq
- Market Cap
- CNTX 67.7M
- CPIX 68.7M
- IPO Year
- CNTX 2021
- CPIX 2009
- Fundamental
- Price
- CNTX $0.81
- CPIX $5.31
- Analyst Decision
- CNTX Strong Buy
- CPIX
- Analyst Count
- CNTX 5
- CPIX 0
- Target Price
- CNTX $6.70
- CPIX N/A
- AVG Volume (30 Days)
- CNTX 147.9K
- CPIX 4.3M
- Earning Date
- CNTX 03-20-2025
- CPIX 03-04-2025
- Dividend Yield
- CNTX N/A
- CPIX N/A
- EPS Growth
- CNTX N/A
- CPIX N/A
- EPS
- CNTX N/A
- CPIX N/A
- Revenue
- CNTX N/A
- CPIX $36,785,442.00
- Revenue This Year
- CNTX N/A
- CPIX N/A
- Revenue Next Year
- CNTX N/A
- CPIX N/A
- P/E Ratio
- CNTX N/A
- CPIX N/A
- Revenue Growth
- CNTX N/A
- CPIX N/A
- 52 Week Low
- CNTX $0.77
- CPIX $1.04
- 52 Week High
- CNTX $2.75
- CPIX $7.19
- Technical
- Relative Strength Index (RSI)
- CNTX 39.82
- CPIX 61.57
- Support Level
- CNTX $0.77
- CPIX $4.12
- Resistance Level
- CNTX $0.87
- CPIX $7.19
- Average True Range (ATR)
- CNTX 0.08
- CPIX 0.99
- MACD
- CNTX 0.01
- CPIX 0.12
- Stochastic Oscillator
- CNTX 20.75
- CPIX 63.21
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.